Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
The Technology and Commercialization (TDC) office is thrilled to recognize Dr.
Naoto Hirano, Senior Scientist at Princess Margaret Cancer Centre, as the winner of UHN's 17th annual Inventor of the Year Award.
Dr. Naoto Hirano receives the 2019 award for his work in developing theTCR-HLA multimer staining technique, which greatly expands how immunotherapy targets cancer, allowing more people to benefit from the treatment.
The TCR-HLA multimer staining technology is part of a branch of cancer immunotherapy known as T-cell receptor-based adoptive cellular therapy, which helps to stimulate the body's own immune response to destroy cancer cells.
The approach Dr. Hirano devised overcomes current immunotherapy targeting limitations that arise from using only a few types of human leukocyte antigens (HLA) during immunotherapy. HLAs are responsible for presenting antigenic peptides to the body in order to stimulate an immune response. The types of HLAs currently available are only found in a small subset of people and ethnic groups. Furthermore, only a select number of peptides, which are present in a fraction of the cancer cells, are used.
TCR-HLA multimer staining enables a wide variety of different types of HLAs and peptides to be used to target cancer. These can be customized to individual patients, greatly expanding the effectiveness and applicability of immunotherapies.
Dr. Hirano is also the scientific co-founder of
TCRyption Inc., a UHN spin-off company that was recently launched to help advance T-cell immunotherapy using this groundbreaking technology. TCRyption Inc.'s commercialization efforts were led by
UHN's TDC securing an initial $10 million in seed financing to advance the innovation towards helping patients.
"We are thrilled to recognize the world-class science, collaboration and commercialization that Dr. Naoto Hirano exemplifies," says Brad Wouters, UHN's Executive Vice President of Science and Research.
"It is exciting to see another UHN and Toronto ecosystem technology making bold strides towards improving health by including a broader spectrum of patients in need."
Congratulations, Dr. Hirano!
About the Inventor of the Year Award
The Inventor of the Year Award is an annual award recognizing UHN researchers who have demonstrated excellence in translating their findings into new technologies, services and products that improve health. These inventions, along with the many other cutting-edge research innovations made at UHN, demonstrate the world-class creativity and impact that UHN researchers are having on the global health care community.
Past Inventor of the Year Winners include: